Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Piramal Expands Scotland Mfg. Ops | Contract Pharma

What are you searching for?

Sign in
Breaking News

Piramal Expands Scotland Mfg. Ops

Invests £2.0 million to expand Grangemouth site to manufacture ADCs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Piramal Healthcare UK Ltd. has invested £2.0 million to expand its manufacturing base at Grangemouth, Scotland, to manufacture Antibody Drug Conjugates for global markets. The new facility will add approximately 20 high-skill jobs and the company expects the investment will yield additional revenue of £3-5 million over a period of five years.
 
Scotland has become a globally competitive base for sustainable high-value manufacturing. Scotland’s globally competitive Pharma services sector includes more than 160 companies, a quality controlled environment, supportive clinical trial environment and high quality manufacture.
  
Piramal Healthcare site lead, Mark Wright, said, “Piramal has been growing its operations in Grangemouth since 2005 and currently employs around 140 people in predominantly highly skilled positions. We aim to scale up this facility in the next five years to maintain its position as a global leader in the production of Antibody Drug Conjugates.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics